CNSP
CNS Pharmaceuticals Inc
NASDAQ: CNSP · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.44% today
Updated 2026-04-30
Market cap
$1.91M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-35.75
Dividend yield
—
52W range
$2 – $17
Volume
0.0M
CNS Pharmaceuticals Inc (CNSP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-296.30%
ROA
-115.30%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-526469.00 | — | — | — |
| 2018 | $0.00 | $-7.39M | — | — | — |
| 2019 | $0.00 | $-3.92M | — | — | — |
| 2020 | $0.00 | $-9.46M | — | — | — |
| 2021 | $0.00 | $-14.50M | — | — | — |
| 2022 | $0.00 | $-15.27M | — | — | — |
| 2023 | $0.00 | $-18.85M | — | — | — |
| 2024 | $0.00 | $-14.86M | — | — | — |
| 2025 | $0.00 | $-15.85M | — | — | — |